Eli Lilly drug shown to slow Alzheimer’s progression
Eli Lilly drug shown to slow Alzheimer’s progression
arstechnica.com Eli Lilly drug shown to slow Alzheimer’s progression
Dementia experts hail "watershed moment" after trial results for donanemab antibody treatment.
![Eli Lilly drug shown to slow Alzheimer’s progression](https://lemmy.world/pictrs/image/72dba7a0-7174-461b-acb1-59562abd670a.png?format=webp&thumbnail=256)
1
comments
Looks promising. It's far from a cure but slowing disease progression and maintaining quality of life a bit longer sounds great. .
Cost and the fact that it's administered by IV will likely limit how many have access to it though.
2 0 Reply